Submit Deal

INMAGENE BIOPHARMACEUTICALS

HQ - San Diego

Summary

Inmagene Biopharmaceuticals is a clinical-stage biotechnology company focused on developing novel therapeutics for immunological, autoimmune, and inflammatory diseases (I&I).

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 71 M

Avg. Deal Size£ 71 M

Market Context

Senior Management

Jonathan Wang
CEO
Anna Vardanyan
Senior Vice President of Corporate and Business Development

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Jonathan Wang
CEO
Anna Vardanyan
Senior Vice President of Corporate and Business Development